表紙
市場調查報告書

全球乾癬治療藥市場

Psoriasis Drugs

出版商 Global Industry Analysts, Inc. 商品編碼 912758
出版日期 內容資訊 英文 245 Pages
商品交期: 最快1-2個工作天內
價格
全球乾癬治療藥市場 Psoriasis Drugs
出版日期: 2019年10月01日內容資訊: 英文 245 Pages
簡介

本報告提供全球乾癬治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球乾癬治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • ABBVIE
  • AMGEN
  • CELGENE CORPORATION
  • ELI LILLY AND COMPANY
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • UCB SA

第5章 調查資料

目錄
Product Code: MCP-6324

Psoriasis Drugs market worldwide is projected to grow by US$10.8 Billion, driven by a compounded growth of 9%. Tumor Necrosis Factor Inhibitor, one of the segments analyzed and sized in this study, displays the potential to grow at over 9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$8.1 Billion by the year 2025, Tumor Necrosis Factor Inhibitor will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$367.7 Million to the region's size and clout in the next 5 to 6 years. Over US$321.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Tumor Necrosis Factor Inhibitor will reach a market size of US$377.2 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 13.2% over the next couple of years and add approximately US$3.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, AbbVie, Inc.; Amgen, Inc.; Celgene Corporation; Eli Lilly and Company; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; UCB SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Psoriasis Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Psoriasis Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Psoriasis Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Psoriasis Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Tumor Necrosis Factor Inhibitor (Therapeutic Class) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Tumor Necrosis Factor Inhibitor (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Tumor Necrosis Factor Inhibitor (Therapeutic Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Interleukin Inhibitors (Therapeutic Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Interleukin Inhibitors (Therapeutic Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Interleukin Inhibitors (Therapeutic Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Other Therapeutic Classes (Therapeutic Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Other Therapeutic Classes (Therapeutic Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Other Therapeutic Classes (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Topicals (Treatment) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Topicals (Treatment) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Topicals (Treatment) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Systemic (Treatment) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Systemic (Treatment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Systemic (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Biologics (Treatment) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Biologics (Treatment) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Biologics (Treatment) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Psoriasis Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 22: United States Psoriasis Drugs Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 23: Psoriasis Drugs Market in the United States by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 24: United States Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 25: United States Psoriasis Drugs Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
    • TABLE 26: Psoriasis Drugs Market in the United States by Treatment: A Historic Review in US$ Million for 2009-2017
    • TABLE 27: United States Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 28: Canadian Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 29: Canadian Psoriasis Drugs Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 30: Psoriasis Drugs Market in Canada: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
    • TABLE 31: Canadian Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
    • TABLE 32: Canadian Psoriasis Drugs Historic Market Review by Treatment in US$ Million: 2009-2017
    • TABLE 33: Psoriasis Drugs Market in Canada: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • JAPAN
    • TABLE 34: Japanese Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 35: Psoriasis Drugs Market in Japan: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 36: Japanese Psoriasis Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 37: Japanese Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
    • TABLE 38: Psoriasis Drugs Market in Japan: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
    • TABLE 39: Japanese Psoriasis Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 40: Chinese Psoriasis Drugs Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 41: Psoriasis Drugs Historic Market Analysis in China in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 42: Chinese Psoriasis Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 43: Chinese Psoriasis Drugs Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
    • TABLE 44: Psoriasis Drugs Historic Market Analysis in China in US$ Million by Treatment: 2009-2017
    • TABLE 45: Chinese Psoriasis Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Psoriasis Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 46: European Psoriasis Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 47: Psoriasis Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 48: European Psoriasis Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 49: European Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 50: Psoriasis Drugs Market in Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 51: European Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 52: European Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
    • TABLE 53: Psoriasis Drugs Market in Europe in US$ Million by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 54: European Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 55: Psoriasis Drugs Market in France by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 56: French Psoriasis Drugs Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 57: French Psoriasis Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 58: Psoriasis Drugs Market in France by Treatment: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 59: French Psoriasis Drugs Historic Market Scenario in US$ Million by Treatment: 2009-2017
    • TABLE 60: French Psoriasis Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 61: Psoriasis Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 62: German Psoriasis Drugs Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 63: German Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 64: Psoriasis Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
    • TABLE 65: German Psoriasis Drugs Historic Market Analysis in US$ Million by Treatment: 2009-2017
    • TABLE 66: German Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 67: Italian Psoriasis Drugs Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 68: Psoriasis Drugs Historic Market Analysis in Italy in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 69: Italian Psoriasis Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 70: Italian Psoriasis Drugs Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
    • TABLE 71: Psoriasis Drugs Historic Market Analysis in Italy in US$ Million by Treatment: 2009-2017
    • TABLE 72: Italian Psoriasis Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 73: United Kingdom Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 74: Psoriasis Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 75: United Kingdom Psoriasis Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 76: United Kingdom Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
    • TABLE 77: Psoriasis Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
    • TABLE 78: United Kingdom Psoriasis Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 79: Spanish Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 80: Spanish Psoriasis Drugs Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 81: Psoriasis Drugs Market in Spain: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
    • TABLE 82: Spanish Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
    • TABLE 83: Spanish Psoriasis Drugs Historic Market Review by Treatment in US$ Million: 2009-2017
    • TABLE 84: Psoriasis Drugs Market in Spain: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 85: Russian Psoriasis Drugs Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 86: Psoriasis Drugs Market in Russia by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 87: Russian Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 88: Russian Psoriasis Drugs Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
    • TABLE 89: Psoriasis Drugs Market in Russia by Treatment: A Historic Review in US$ Million for 2009-2017
    • TABLE 90: Russian Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 91: Rest of Europe Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 92: Psoriasis Drugs Market in Rest of Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 93: Rest of Europe Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 94: Rest of Europe Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
    • TABLE 95: Psoriasis Drugs Market in Rest of Europe in US$ Million by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 96: Rest of Europe Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 97: Asia-Pacific Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 98: Psoriasis Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 99: Asia-Pacific Psoriasis Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 100: Psoriasis Drugs Market in Asia-Pacific by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 101: Asia-Pacific Psoriasis Drugs Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 102: Asia-Pacific Psoriasis Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 103: Psoriasis Drugs Market in Asia-Pacific by Treatment: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 104: Asia-Pacific Psoriasis Drugs Historic Market Scenario in US$ Million by Treatment: 2009-2017
    • TABLE 105: Asia-Pacific Psoriasis Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 106: Psoriasis Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 107: Australian Psoriasis Drugs Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 108: Australian Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 109: Psoriasis Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
    • TABLE 110: Australian Psoriasis Drugs Historic Market Analysis in US$ Million by Treatment: 2009-2017
    • TABLE 111: Australian Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 112: Indian Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 113: Indian Psoriasis Drugs Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 114: Psoriasis Drugs Market in India: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
    • TABLE 115: Indian Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
    • TABLE 116: Indian Psoriasis Drugs Historic Market Review by Treatment in US$ Million: 2009-2017
    • TABLE 117: Psoriasis Drugs Market in India: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 118: Psoriasis Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 119: South Korean Psoriasis Drugs Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 120: Psoriasis Drugs Market Share Distribution in South Korea by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 121: Psoriasis Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
    • TABLE 122: South Korean Psoriasis Drugs Historic Market Analysis in US$ Million by Treatment: 2009-2017
    • TABLE 123: Psoriasis Drugs Market Share Distribution in South Korea by Treatment: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 125: Psoriasis Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 126: Rest of Asia-Pacific Psoriasis Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 127: Rest of Asia-Pacific Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
    • TABLE 128: Psoriasis Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
    • TABLE 129: Rest of Asia-Pacific Psoriasis Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 130: Latin American Psoriasis Drugs Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 131: Psoriasis Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 132: Latin American Psoriasis Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 133: Latin American Psoriasis Drugs Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 134: Psoriasis Drugs Historic Market Analysis in Latin America in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 135: Latin American Psoriasis Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 136: Latin American Psoriasis Drugs Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
    • TABLE 137: Psoriasis Drugs Historic Market Analysis in Latin America in US$ Million by Treatment: 2009-2017
    • TABLE 138: Latin American Psoriasis Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 139: Argentinean Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 140: Psoriasis Drugs Market in Argentina in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 141: Argentinean Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 142: Argentinean Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
    • TABLE 143: Psoriasis Drugs Market in Argentina in US$ Million by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 144: Argentinean Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 145: Psoriasis Drugs Market in Brazil by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 146: Brazilian Psoriasis Drugs Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 147: Brazilian Psoriasis Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 148: Psoriasis Drugs Market in Brazil by Treatment: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 149: Brazilian Psoriasis Drugs Historic Market Scenario in US$ Million by Treatment: 2009-2017
    • TABLE 150: Brazilian Psoriasis Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 151: Psoriasis Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 152: Mexican Psoriasis Drugs Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 153: Mexican Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 154: Psoriasis Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
    • TABLE 155: Mexican Psoriasis Drugs Historic Market Analysis in US$ Million by Treatment: 2009-2017
    • TABLE 156: Mexican Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 157: Rest of Latin America Psoriasis Drugs Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 158: Psoriasis Drugs Market in Rest of Latin America by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 159: Rest of Latin America Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 160: Rest of Latin America Psoriasis Drugs Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
    • TABLE 161: Psoriasis Drugs Market in Rest of Latin America by Treatment: A Historic Review in US$ Million for 2009-2017
    • TABLE 162: Rest of Latin America Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 163: The Middle East Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 164: Psoriasis Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 165: The Middle East Psoriasis Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 166: The Middle East Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 167: The Middle East Psoriasis Drugs Historic Market by Therapeutic Class in US$ Million: 2009-2017
    • TABLE 168: Psoriasis Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
    • TABLE 169: The Middle East Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
    • TABLE 170: The Middle East Psoriasis Drugs Historic Market by Treatment in US$ Million: 2009-2017
    • TABLE 171: Psoriasis Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • IRAN
    • TABLE 172: Iranian Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 173: Psoriasis Drugs Market in Iran: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
    • TABLE 174: Iranian Psoriasis Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 175: Iranian Market for Psoriasis Drugs: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
    • TABLE 176: Psoriasis Drugs Market in Iran: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
    • TABLE 177: Iranian Psoriasis Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 178: Israeli Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
    • TABLE 179: Psoriasis Drugs Market in Israel in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
    • TABLE 180: Israeli Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 181: Israeli Psoriasis Drugs Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
    • TABLE 182: Psoriasis Drugs Market in Israel in US$ Million by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 183: Israeli Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 184: Saudi Arabian Psoriasis Drugs Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 185: Psoriasis Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 186: Saudi Arabian Psoriasis Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 187: Saudi Arabian Psoriasis Drugs Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
    • TABLE 188: Psoriasis Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Treatment: 2009-2017
    • TABLE 189: Saudi Arabian Psoriasis Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 190: Psoriasis Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 191: United Arab Emirates Psoriasis Drugs Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 192: Psoriasis Drugs Market Share Distribution in United Arab Emirates by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 193: Psoriasis Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
    • TABLE 194: United Arab Emirates Psoriasis Drugs Historic Market Analysis in US$ Million by Treatment: 2009-2017
    • TABLE 195: Psoriasis Drugs Market Share Distribution in United Arab Emirates by Treatment: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 196: Psoriasis Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
    • TABLE 197: Rest of Middle East Psoriasis Drugs Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
    • TABLE 198: Rest of Middle East Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 199: Psoriasis Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
    • TABLE 200: Rest of Middle East Psoriasis Drugs Historic Market Analysis in US$ Million by Treatment: 2009-2017
    • TABLE 201: Rest of Middle East Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 202: African Psoriasis Drugs Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
    • TABLE 203: Psoriasis Drugs Market in Africa by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
    • TABLE 204: African Psoriasis Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
    • TABLE 205: African Psoriasis Drugs Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
    • TABLE 206: Psoriasis Drugs Market in Africa by Treatment: A Historic Review in US$ Million for 2009-2017
    • TABLE 207: African Psoriasis Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBVIE
  • AMGEN
  • CELGENE CORPORATION
  • ELI LILLY AND COMPANY
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • UCB SA

V. CURATED RESEARCH